Could cause temporary or reversible harm; serious harm is unlikely.
Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.
| Brand name | ATORVASTATIN CALCIUM |
| Generic name | ATORVASTATIN CALCIUM |
| Active ingredient(s) | ATORVASTATIN CALCIUM TRIHYDRATE |
| Distributed by / for | Mylan Pharmaceuticals Inc. |
| NDC | 0378-3953-09 |
| Full product label | Atorvastatin Calcium Tablets, 80 mg*, packaged in a) 90-count bottles (NDC 0378-3953-09) and b) 500-count bottles (NDC 0378-3953-07), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A. |
| Recalling firm | Mylan Pharmaceuticals Inc. |
| Distribution | Nationwide in the USA and Puerto Rico |
| Quantity | 452,269 bottles |
| Recall initiated | 2017-03-20 |
| Report date | 2017-04-05 |
| Recall completed | 2018-01-26 |
| Recall number | D-0621-2017 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Morgantown WV United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗